Sayer HG - Search Results

1

Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia.

Pfirrmann M, Saussele S, Hochhaus A, Reiter A, Berger U, Hossfeld DK, Nerl C, Scheid C, Spiekermann K, Mayer J, Hellmann A, Lechner K, Falge C, Sayer HG, Bunjes D, Ganser A, Beelen DW, Baldomero H, Schanz U, Heimpel H, Kolb HJ, Hasford J, Gratwohl A, Hehlmann R; Schweizerische Arbeitsgemeinschaft für Klinische Forschung (SAKK); German CML Study Group. Pfirrmann M, et al. Among authors: sayer hg. J Cancer Res Clin Oncol. 2014 Aug;140(8):1367-81. doi: 10.1007/s00432-014-1662-y. Epub 2014 Apr 10. J Cancer Res Clin Oncol. 2014. PMID: 24718719

2

Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.

Beelen DW, Haralambie E, Brandt H, Linzenmeier G, Müller KD, Quabeck K, Sayer HG, Graeven U, Mahmoud HK, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Blood. 1992 Nov 15;80(10):2668-76. Blood. 1992. PMID: 1421380 Free article.

3

[Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation].

Beelen DW, Quabeck K, Mahmoud HK, Sayer HG, Kraft J, Graeven U, Grosse-Wilde H, Quast U, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Dtsch Med Wochenschr. 1991 Mar 15;116(11):401-10. doi: 10.1055/s-2008-1063625. Dtsch Med Wochenschr. 1991. PMID: 2001649 German.

4

Influence of treatment modality, patient/donor characteristics, and disease stage on the risk of relapse after allogeneic marrow transplantation for acute leukemia.

Beelen DW, Quabeck K, Graeven U, Sayer HG, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Haematol Blood Transfus. 1990;33:688-91. doi: 10.1007/978-3-642-74643-7_125. Haematol Blood Transfus. 1990. PMID: 2323667 No abstract available.

5

Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia.

Beelen DW, Quabeck K, Graeven U, Sayer HG, Mahmoud HK, Schaefer UW. Beelen DW, et al. Among authors: sayer hg. Blood. 1989 Oct;74(5):1507-16. Blood. 1989. PMID: 2790182 Free article.

6

Bone marrow transplantation for myeloblastoma.

Quabeck K, Beelen DW, Mahmoud HK, Sayer HG, Graeven U, Schaefer UW, Schmidt CG, Hossfeld DK. Quabeck K, et al. Among authors: sayer hg. Eur J Haematol. 1988 Aug;41(2):186-8. doi: 10.1111/j.1600-0609.1988.tb00890.x. Eur J Haematol. 1988. PMID: 3044821

7

Bone marrow transplantation from partially HLA-matched related donors in adults with leukaemia: the experience at the University Hospital of Essen, Germany.

Ottinger H, Beelen D, Sayer H, Schaefer UW, Grosse-Wilde H. Ottinger H, et al. Br J Haematol. 1996 Mar;92(4):913-21. doi: 10.1046/j.1365-2141.1996.438977.x. Br J Haematol. 1996. PMID: 8616085 Clinical Trial.

8

Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.

Ottinger HD, Müller CR, Goldmann SF, Albert E, Arnold R, Beelen DW, Blasczyk R, Bunjes D, Casper J, Ebell W, Ehninger G, Eiermann T, Einsele H, Fauser A, Ferencik S, Finke J, Hertenstein B, Heyll A, Klingebiel T, Knipper A, Kremens B, Kolb HJ, Kolbe K, Lenartz E, Lindemann M, Müller CA, Mytilineos J, Niederwieser D, Runde V, Sayer H, Schaefer UW, Schmitz N, Schröder S, Schulze-Rath R, Schwerdtfeger R, Siegert W, Thiele B, Zander AR, Grosse-Wilde H. Ottinger HD, et al. Ann Hematol. 2001 Dec;80(12):706-14. doi: 10.1007/s00277-001-0384-9. Epub 2001 Oct 25. Ann Hematol. 2001. PMID: 11797110 Review.

9

Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation-- successful treatment with high-dose methylprednisolone and defibrotide.

Sayer HG, Will U, Schilling K, Vogt T, Wollina K, Höffken K. Sayer HG, et al. J Cancer Res Clin Oncol. 2002 Mar;128(3):148-52. doi: 10.1007/s00432-001-0316-z. Epub 2002 Jan 22. J Cancer Res Clin Oncol. 2002. PMID: 11935301

10

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease.

Arnold R, Massenkeil G, Bornhäuser M, Ehninger G, Beelen DW, Fauser AA, Hegenbart U, Hertenstein B, Ho AD, Knauf W, Kolb HJ, Kolbe K, Sayer HG, Schwerdtfeger R, Wandt H, Hoelzer D. Arnold R, et al. Among authors: sayer hg. Leukemia. 2002 Dec;16(12):2423-8. doi: 10.1038/sj.leu.2402712. Leukemia. 2002. PMID: 12454748 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page